Biosimilars Europe Congress 2016

  • 22-23 Nov 2016
  • Hilton London Olympia, United Kingdom

Description

The Biosimilars Europe Congress 2016 is dedicated to latest Development in Biosimilars and the BREXIT Implications.

The Biosimilars Europe Congress 2016 covers topics such as:

  • Challenges faced when moving towards globalization
  • Current status of Biosimliars market
  • IP issues
  • Opportunities in emerging markets
  • Partnership
  • Naming and labeling issues related to biosimilars
  • Challenges and opportunities for biobetters and monoclonal antibody biosimilars
  • New investment and business models
  • Benefits and concerns of interchangeable and biosubstitutes and post authorization monitoring
  • Clinical trials strategies and new guidelines for biosimilar clinical trials
  • New solutions to demonstrate similarity and different characterization methods
  • Bringing biosimilars closer to patients and healthcare professionals
  • BREXIT Implications

The Biosimilars Europe Congress 2016 brings together senior attendees from:

  • Clinical Development
  • Biosimilar Development
  • Commercial Development
  • Global Strategy
  • Biosimilar Analysis
  • Biologics Regulation
  • Regulatory Affairs
  • Medical Affairs
  • Regulatory Compliance
  • Biobetter Development
  • Biosimilar Process Development
  • Biologics Development
  • Follow-On Biologics
  • Biosuperiors Portfolio Management
  • Legal Affairs Strategic Marketing
  • Strategic Planning
  • Research & Development
  • Commercial Affairs and Development
  • Pharmacovigilance
  • Market Access
  • SBMP
  • Market Entry

Past Events

Important

Please, check "Biosimilars Europe Congress" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Pharma
Science: Biochemistry, Health sciences, Life Sciences & Biology
Technology: Biotechnology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions